News
Codex DNA, Inc. is a new focused synthetic biology company developing lab instruments, reagents, and associated products while providing various other services. Codex DNA's products include the ...
Codex DNA, fresh off raising $122 million in an initial public stock offering in June, has inked a deal to buy privately held Eton Bioscience — combining two of San Diego’s synthetic biology ...
SAN DIEGO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of a new full-length synthetic ...
Codex DNA (DNAY) is a $267m market cap biotech that IPOd in June last year, raising $123m at $16 per share. The company was spun out of Synthetic Genomics (since renamed Viridos) in 2019, having ...
-- Acquisition will allow Codex DNA to expand its commercial BioXp™ system and biofoundry service offerings, reduce raw material costs, and accelerate overall growth strategy --SAN DIEGO, Nov ...
What happenedWednesday will go down in history for Codex DNA (NASDAQ: DNAY). The genetics-focused biotech saw its share price rocket 39% higher, thanks to a potentially very lucrative deal with a ...
San Diego, April 06, 2020 (GLOBE NEWSWIRE) -- SGI-DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp™ 3200 system, today announced ...
Codex DNA is well capitalized with cash and short-term investments of $61.9 million as of June 30, 2022. Revenue was $5.7 million for the second quarter 2022, ...
--Codex DNA, Inc., a pioneer in automated benchtop synthetic biology systems, today announced its speaker presentation for the World Vaccine Congress Washington 2022, which is being held in ...
Todd R. Nelson, Ph.D., has served as the President, Chief Executive Officer and a member of the board of directors of Codex DNA (NASDAQ:DNAY) since July 2018. Prior to joining the company, Dr ...
On August 10, Codex DNA will present Q2 figures.Analysts on Wall Street predict Codex DNA will release losses per share of $0.320.Go here to watch ...
Good day, and thank you for standing by. Welcome to the second-quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results